Literature DB >> 6500078

Immunoreactive relaxin surge in the peritoneal fluid of women during the midluteal phase.

E Loumaye, S Depreester, J Donnez, K Thomas.   

Abstract

Relaxin was assayed in the peritoneal fluid (PF) of 176 women with normal ovulatory cycles. Validation of the assay in this fluid was carefully established. Relaxin was rarely detected before day 20 of the cycle. From days 21 to 24, all samples contained detectable concentrations of the peptide, ranging between 75 and 775 pg/ml. Apparition of relaxin in the PF was not directly related to the ovulatory follicular rupture. It was also delayed, compared with the postovulatory rise of plasma and peritoneal progesterone. Relaxin is thus present in the PF only during the period propitious to human embryo implantation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6500078     DOI: 10.1016/s0015-0282(16)48256-7

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

1.  Hormonal changes throughout the menstrual cycle and increased anterior cruciate ligament laxity in females.

Authors:  N A Heitz; P A Eisenman; C L Beck; J A Walker
Journal:  J Athl Train       Date:  1999-04       Impact factor: 2.860

2.  Primate preimplantation embryo is a target for relaxin during early pregnancy.

Authors:  Catherine A Vandevoort; Namdori R Mtango; Keith E Latham; Dennis R Stewart
Journal:  Fertil Steril       Date:  2011-06-08       Impact factor: 7.329

3.  Potential influence of the corpus luteum on circulating reproductive and volume regulatory hormones, angiogenic and immunoregulatory factors in pregnant women.

Authors:  Kirk P Conrad; Georgia M Graham; Yueh-Yun Chi; Xiaoman Zhai; Minjie Li; R Stan Williams; Alice Rhoton-Vlasak; Mark S Segal; Charles E Wood; Maureen Keller-Wood
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-08-13       Impact factor: 4.310

4.  Contribution to More Patient-Friendly ART Treatment: Efficacy of Continuous Low-Dose GnRH Agonist as the Only Luteal Support-Results of a Prospective, Randomized, Comparative Study.

Authors:  Céline Pirard; Ernest Loumaye; Pascale Laurent; Christine Wyns
Journal:  Int J Endocrinol       Date:  2015-04-05       Impact factor: 3.257

5.  Efficacy of daily GnRH agonist for luteal phase support following GnRH agonist triggered ICSI cycles versus conventional strategy: A Randomized controlled trial.

Authors:  Saghar Salehpour; Leila Nazari; Sedighe Hosseini; Elham Azizi; Nasrin Borumandnia; Teibeh Hashemi
Journal:  JBRA Assist Reprod       Date:  2021-07-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.